About Francis Cuss
Francis Cuss is a director at Mural Oncology plc.
Form D filings name Francis Cuss as a director at SunBird Bio.
Francis Cuss reports to the SEC as a director or officer of 3 public companies, including Rubius Therapeutics (RUBY) and Bristol Myers Squibb (BMY).
Francis Cuss first appears on SEC filings in 2010.
Experience
This experience comes from SEC filings. The years are when the filings name Francis Cuss in the role, so the role may have started earlier or lasted longer.
MP
Mural Oncology plc
Director
2023 – 2025 · Public company (MURA)
RI
Rubius Therapeutics, Inc.
Director
2018 – 2022 · Public company (RUBY)
BC
Bristol Myers Squibb Co.
EVP & CSO
2010 – 2017 · Public company (BMY)
Key Colleagues at Startups
The people Francis Cuss works with at each company, as listed on that company's latest Form D.
SunBird Bio, Inc. · Form D, Dec 17, 2021
CL
Caroline Loew
Chief Executive Officer and director
TG
Theresia Gouw
Director
AS
Amy Schulman
Director
SL
Stanley Lapidus
Director
Robert Langer
Director
TT
Tram Tran
Executive officer
SK
Steve Kafka
Director
WA
Wendy Adamovich
Executive officer
JA
Jessica Atkinson
Executive officer
DG
Dhaval Gosalia
Executive officer
MN
Matthew Navarro
Executive officer
GZ
George Zachary
Director